These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 19846982
1. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study. Grosso M, Chiacchio S, Bianchi F, Traino C, Marini C, Cilotti A, Manca G, Volterrani D, Roncella M, Rampin L, Marzola MC, Rubello D, Mariani G. Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982 [Abstract] [Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW. Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [Abstract] [Full Text] [Related]
3. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves. Buscombe JR, Cwikla JB, Holloway B, Hilson AJ. J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976 [Abstract] [Full Text] [Related]
4. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis. Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS. Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043 [Abstract] [Full Text] [Related]
5. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer]. Cwikła JB, Buscombe JR, Kolasińska AD, Holloway B, Hilson AJ. Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463 [Abstract] [Full Text] [Related]
10. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer. Paz A, Melloul M, Cytron S, Koren R, Ohana G, Michalevich D, Gal R, Wolloch Y. Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222 [Abstract] [Full Text] [Related]
11. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions. Liu L, Song Y, Gao S, Ji T, Zhang H, Ji B, Chen B, Jia B, Wang F, Xu Z, Ma Q. Mol Imaging; 2014 Apr; 13(5):. PubMed ID: 24825112 [Abstract] [Full Text] [Related]
13. Tc 99m-Sestamibi scintimammography in the differentiation of benign and malignant breast microcalcifications. Marini C, Cilotti A, Traino AC, Bellina CR, Grosso M, Armillotta N, Volterrani D, Bartolozzi C. Breast; 2001 Aug; 10(4):306-12. PubMed ID: 14965599 [Abstract] [Full Text] [Related]
15. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Stipsanelli A, Louvrou A, Lazaris D, Sotiropoulou M, Pampouras G, Keramopoulos A, Michalas S, Zerva C. Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092 [Abstract] [Full Text] [Related]
17. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Cwikla JB, Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Deery AR, Crow J, Hilson AJ. Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043 [Abstract] [Full Text] [Related]